Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
NovaBay Pharmaceuticals, Inc. See All Filings	D	2026-01-27 12:43:08 UTC
Amount To Be Raised $134,000,000 Associated Brokers / Dealers N/A CIK Number 0001389545 Filed Document 0001389545-26-000001 Exclusions or Exemptions 506b Accepted Date 2026-01-27 12:43:08 UTC Type of Offering D Industry Other Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
NovaBay Pharmaceuticals, Inc. See All Filings	D	2024-06-28 15:19:29 UTC
Amount To Be Raised $225,953 Associated Brokers / Dealers Ladenburg Thalmann & Co. Inc. CIK Number 0001389545 Filed Document 0002028644-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-06-28 15:19:29 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
NovaBay Pharmaceuticals, Inc. See All Filings	D	2024-04-05 12:27:23 UTC
Amount To Be Raised $665,000 Associated Brokers / Dealers Ladenburg Thalmann & Co. Inc. CIK Number 0001389545 Filed Document 0002016056-24-000003 Exclusions or Exemptions 506b Accepted Date 2024-04-05 12:27:23 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt
NovaBay Pharmaceuticals, Inc. See All Filings	D	2024-01-04 11:50:36 UTC
Amount To Be Raised $554,808 Associated Brokers / Dealers LADENBURG THALMANN & CO, INC. CIK Number 0001389545 Filed Document 0001977207-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-01-04 11:50:36 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
NovaBay Pharmaceuticals, Inc. See All Filings	D	2023-05-18 17:15:15 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers LADENBURG THALMANN & CO. INC. CIK Number 0001389545 Filed Document 0001437749-23-015159 Exclusions or Exemptions 506b Accepted Date 2023-05-18 17:15:15 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt
NovaBay Pharmaceuticals, Inc. See All Filings	D	2022-09-23 15:40:47 UTC
Amount To Be Raised $3,250,000 Associated Brokers / Dealers LADENBURG THALMANN & CO. INC. CIK Number 0001389545 Filed Document 0001947812-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-09-23 15:40:47 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
NovaBay Pharmaceuticals, Inc. See All Filings	D	2022-09-23 15:18:46 UTC
Amount To Be Raised $2,065,500 Associated Brokers / Dealers LADENBURG THALMANN & CO. INC. CIK Number 0001389545 Filed Document 0001947812-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-09-23 15:18:46 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
NovaBay Pharmaceuticals, Inc. See All Filings	D	2021-11-17 15:18:32 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers Ladenburg Thalmann & Co. Inc. CIK Number 0001389545 Filed Document 0001553504-21-000005 Exclusions or Exemptions 506b Accepted Date 2021-11-17 15:18:32 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
NovaBay Pharmaceuticals, Inc. See All Filings	D	2020-07-31 09:25:51 UTC
Amount To Be Raised $6,829,580 Associated Brokers / Dealers N/A CIK Number 0001389545 Filed Document 0001819710-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-07-31 09:25:51 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
NovaBay Pharmaceuticals, Inc. See All Filings	D	2020-05-22 08:23:19 UTC
Amount To Be Raised $1,731,030 Associated Brokers / Dealers N/A CIK Number 0001389545 Filed Document 0001553610-20-000004 Exclusions or Exemptions 506b Accepted Date 2020-05-22 08:23:19 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
NovaBay Pharmaceuticals, Inc. See All Filings	D	2020-05-01 08:22:06 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001389545 Filed Document 0001553610-20-000003 Exclusions or Exemptions 506b Accepted Date 2020-05-01 08:22:06 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
NovaBay Pharmaceuticals, Inc. See All Filings	D	2019-08-26 14:11:04 UTC
Amount To Be Raised $4,198,566 Associated Brokers / Dealers LADENBURG THALMANN & CO. INC. CIK Number 0001389545 Filed Document 0001783954-19-000002 Exclusions or Exemptions 506b Accepted Date 2019-08-26 14:11:04 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
NovaBay Pharmaceuticals, Inc. See All Filings	D	2019-08-26 14:06:02 UTC
Amount To Be Raised $2,700,000 Associated Brokers / Dealers CHINA KINGTON ASSET MANAGEMENT CO. LTD CIK Number 0001389545 Filed Document 0001783954-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-08-26 14:06:02 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
NovaBay Pharmaceuticals, Inc. See All Filings	D	2019-07-03 14:27:11 UTC
Amount To Be Raised $2,400,000 Associated Brokers / Dealers CHINA KINGTON ASSET MANAGEMENT CO. LTD. CIK Number 0001389545 Filed Document 0001781109-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-07-03 14:27:11 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
NovaBay Pharmaceuticals, Inc. See All Filings	D	2018-02-14 14:18:35 UTC
Amount To Be Raised $5,984,000 Associated Brokers / Dealers China Kington Asset Management Co. Ltd. CIK Number 0001389545 Filed Document 0001723123-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-02-14 14:18:35 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
NovaBay Pharmaceuticals, Inc. See All Filings	D	2016-05-20 16:55:13 UTC
Amount To Be Raised $11,791,000 Associated Brokers / Dealers China Kington Asset Management Co. Ltd. CIK Number 0001389545 Filed Document 0001437749-16-032590 Exclusions or Exemptions 506b Accepted Date 2016-05-20 16:55:13 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
NovaBay Pharmaceuticals, Inc. See All Filings	D	2016-02-26 00:00:00 UTC
Amount To Be Raised $2,830,804 Associated Brokers / Dealers China Kington Asset Management Co. Ltd. CIK Number 0001389545 Filed Document 0001437749-16-026178 Exclusions or Exemptions 506b Accepted Date 2016-02-26 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
NovaBay Pharmaceuticals, Inc. See All Filings	D/A	2015-06-03 00:00:00 UTC
Amount To Be Raised $26,582,871 Associated Brokers / Dealers Maxim Group LLC CIK Number 0001389545 Filed Document 0001389545-15-000004 Exclusions or Exemptions 506b Accepted Date 2015-06-03 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
NovaBay Pharmaceuticals, Inc. See All Filings	D	2015-03-19 00:00:00 UTC
Amount To Be Raised $15,134,300 Associated Brokers / Dealers Maxim Group LLC CIK Number 0001389545 Filed Document 0001389545-15-000003 Exclusions or Exemptions 506b Accepted Date 2015-03-19 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity